L&G Pharma Breakthrough UCITS ETF (BIGT.L) — ETF Analysis on Winston

Key Facts

• Issuer: L&G
• Category: Equity
• Asset Class: Equity
• Price: $1,154.40
• Expense Ratio: 49.00%
• Assets Under Management: $15M
• Number of Holdings: 0
• Inception Date: 2018-01-23
• Currency: GBP

Winston Score

L&G Pharma Breakthrough UCITS ETF has a Winston Score of 52 out of 100.

Performance

• 1-Year Return: 28.50%
• 3-Year Return: 27.96%
• 5-Year Return: 17.27%

Top Holdings

TRAVERE THERAPEUTICS INC USD 0.0001 (N/A%), XENCOR INC USD 0.01 (N/A%), LIGAND PHARMACEUTICALS IN USD 0.001 (N/A%), JAZZ PHARMACEUTICALS PLC USD 0.0001 (N/A%), XERIS BIOPHARMA HLDGS IN USD 0.0001 (N/A%)

Sector Breakdown

Basic Materials (N/A%), Healthcare (N/A%)